These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 16328570)

  • 1. Causal proportional hazards models and time-constant exposure in randomized clinical trials.
    Loeys T; Goetghebeur E; Vandebosch A
    Lifetime Data Anal; 2005 Dec; 11(4):435-49. PubMed ID: 16328570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causal interactions in the proportional hazards model.
    VanderWeele TJ
    Epidemiology; 2011 Sep; 22(5):713-7. PubMed ID: 21558856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principal stratification analysis of noncompliance with time-to-event outcomes.
    Liu B; Wruck L; Li F
    Biometrics; 2024 Jan; 80(1):. PubMed ID: 38281770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bias of the additive hazard model in the presence of causal effect heterogeneity.
    Post RAJ; van den Heuvel ER; Putter H
    Lifetime Data Anal; 2024 Apr; 30(2):383-403. PubMed ID: 38466520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The built-in selection bias of hazard ratios formalized using structural causal models.
    Post RAJ; van den Heuvel ER; Putter H
    Lifetime Data Anal; 2024 Apr; 30(2):404-438. PubMed ID: 38358572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causal interpretation of the hazard ratio in randomized clinical trials.
    Fay MP; Li F
    Clin Trials; 2024 Apr; ():17407745241243308. PubMed ID: 38679930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiply robust estimation of principal causal effects with noncompliance and survival outcomes.
    Cheng C; Guo Y; Liu B; Wruck L; Li F; Li F
    Clin Trials; 2024 May; ():17407745241251773. PubMed ID: 38813813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discussion on "Instrumental variable estimation of the causal hazard ratio" by Linbo Wang, Eric Tchetgen Tchetgen, Torben Martinussen, and Stijn Vansteelandt.
    O'Malley AJ; Martínez-Camblor P; MacKenzie TA
    Biometrics; 2023 Jun; 79(2):559-563. PubMed ID: 36427240
    [No Abstract]   [Full Text] [Related]  

  • 9. Nonparametric Bounds and Sensitivity Analysis of Treatment Effects.
    Richardson A; Hudgens MG; Gilbert PB; Fine JP
    Stat Sci; 2014 Nov; 29(4):596-618. PubMed ID: 25663743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why test for proportional hazards-or any other model assumptions?
    Sjölander A; Dickman PW
    Am J Epidemiol; 2024 Jun; 193(6):926-927. PubMed ID: 38319720
    [No Abstract]   [Full Text] [Related]  

  • 11. Comment on "Causal interpretation of the hazard ratio in randomized clinical trials" by Fay and Li.
    Heitjan DF
    Clin Trials; 2024 Apr; ():17407745241243307. PubMed ID: 38679937
    [No Abstract]   [Full Text] [Related]  

  • 12. Instrumental variable analysis for cost outcome: Application to the effect of primary care visit on medical cost among low-income adults.
    Gao D; Hu J; Bradley CJ; Yang F
    Stat Med; 2023 Oct; 42(24):4349-4376. PubMed ID: 37828812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Instrumental variable estimation of the marginal structural Cox model for time-varying treatments.
    Cui Y; Michael H; Tanser F; Tchetgen Tchetgen E
    Biometrika; 2023 Mar; 110(1):101-118. PubMed ID: 36798841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Instrumental variable approach for estimating a causal hazard ratio: application to the effect of postmastectomy radiotherapy on breast cancer patients.
    Yang F; Cheng J; Huo D
    Obs Stud; 2019; 5():141-162. PubMed ID: 34223564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A semiparametric linear transformation model to estimate causal effects for survival data.
    Lin H; Li Y; Jiang L; Li G
    Can J Stat; 2014 Mar; 42(1):18-35. PubMed ID: 31660001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On two-stage estimation of structural instrumental variable models.
    Choi BY; Fine JP; Brookhart MA
    Biometrika; 2017 Dec; 104(4):881-899. PubMed ID: 29430042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Instrumental variables estimation of exposure effects on a time-to-event endpoint using structural cumulative survival models.
    Martinussen T; Vansteelandt S; Tchetgen Tchetgen EJ; Zucker DM
    Biometrics; 2017 Dec; 73(4):1140-1149. PubMed ID: 28493302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Instrumental variable estimation in a survival context.
    Tchetgen Tchetgen EJ; Walter S; Vansteelandt S; Martinussen T; Glymour M
    Epidemiology; 2015 May; 26(3):402-10. PubMed ID: 25692223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity Analysis of Per-Protocol Time-to-Event Treatment Efficacy in Randomized Clinical Trials.
    Gilbert PB; Shepherd BE; Hudgens MG
    J Am Stat Assoc; 2013 Jan; 108(503):. PubMed ID: 24187408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonparametric inference for assessing treatment efficacy in randomized clinical trials with a time-to-event outcome and all-or-none compliance.
    Elashoff RM; Li G; Zhou Y
    Biometrika; 2012 Jun; 99(2):393-404. PubMed ID: 23843664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.